BIO-key adjourns annual shareholder meeting to Oct. 2 after insufficient votes on warrant proposal
Reuters2026/09/08 21:04- BIO-key delayed its 2026 annual shareholder meeting due to insufficient votes to pass Proposal 4.
- Proposal 4 seeks Nasdaq rule approval for issuing up to 1,236,668 common shares from warrants tied to an Aug. 10, 2026 inducement.
- Meeting will reconvene Oct. 2, 2026 at 10:00 a.m. at its Holmdel, New Jersey offices; polls remain open.
- Record date stays July 15, 2026; shareholders who have not voted on Proposal 4 must submit a new proxy.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The higher the yen rises, the more retail investors short! 3.61 trillion yen short bets defy the trend, triggering a short squeeze warning
Even though the yen has reached its highest level in months, Japanese retail investors continue to bet that its sharp rebound will come to an end, and are consistently increasing their short positions.
EUR/USD Price Forecast: Bullish bias remains above 1.1600 ahead of ECB and US inflation
Abraxas Capital hedges $353M ETH short with $32M buy – Here’s why
Pons propels Robinhood Chain fees to record $6 million in daily fees as DEX volume doubles
Crypto prices
More
